数字微流控生物芯片:迈向功能多样性,超过摩尔,和网络物理集成

K. Chakrabarty
{"title":"数字微流控生物芯片:迈向功能多样性,超过摩尔,和网络物理集成","authors":"K. Chakrabarty","doi":"10.1145/2742060.2745701","DOIUrl":null,"url":null,"abstract":"Advances in droplet-based \"digital\" microfluidics have led to the emergence of biochip devices for automating laboratory procedures in biochemistry and molecular biology. These devices enable the precise control of nanoliter-volume droplets of biochemical samples and reagents. Therefore, integrated circuit (IC) technology can be used to transport and transport \"chemical payload\" in the form of micro/nanofluidic droplets. As a result, non-traditional biomedical applications and markets (e.g., high-throughout DNA sequencing, portable and point-of-care clinical diagnostics, protein crystallization for drug discovery), and fundamentally new uses are opening up for ICs and systems. However, continued growth depends on advances in chip integration and design-automation tools. Design automation is needed to ensure that biochips are as versatile as the macro-labs that they are intended to replace, and researchers can thereby envision an automated design flow for biochips, in the same way as design automation revolutionized IC design in the 80s and 90s. This talk will first provide an overview of market drivers such as immunoassays, DNA sequencing, clinical chemistry, etc., and electrowetting-based digital microfludic biochips. The audience will next learn about design automation, design-for-testability, and reconfiguration aspects of digital microfluidic biochips. Synthesis tools will be described to map assay protocols from the lab bench to a droplet-based microfluidic platform and generate an optimized schedule of bioassay operations, the binding of assay operations to functional units, and the layout and droplet-flow paths for the biochip. The role of the digital microfluidic platform as a \"programmable and reconfigurable processor\" for biochemical applications will be highlighted. Finally, the speaker will demonstrate dynamic adaptation of bioassays through cyberphysical system integration and sensor-driven on-chip error recovery.","PeriodicalId":255133,"journal":{"name":"Proceedings of the 25th edition on Great Lakes Symposium on VLSI","volume":"15 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2015-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Digital Microfluidic Biochips: Towards Functional Diversity, More than Moore, and Cyberphysical Integration\",\"authors\":\"K. Chakrabarty\",\"doi\":\"10.1145/2742060.2745701\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Advances in droplet-based \\\"digital\\\" microfluidics have led to the emergence of biochip devices for automating laboratory procedures in biochemistry and molecular biology. These devices enable the precise control of nanoliter-volume droplets of biochemical samples and reagents. Therefore, integrated circuit (IC) technology can be used to transport and transport \\\"chemical payload\\\" in the form of micro/nanofluidic droplets. As a result, non-traditional biomedical applications and markets (e.g., high-throughout DNA sequencing, portable and point-of-care clinical diagnostics, protein crystallization for drug discovery), and fundamentally new uses are opening up for ICs and systems. However, continued growth depends on advances in chip integration and design-automation tools. Design automation is needed to ensure that biochips are as versatile as the macro-labs that they are intended to replace, and researchers can thereby envision an automated design flow for biochips, in the same way as design automation revolutionized IC design in the 80s and 90s. This talk will first provide an overview of market drivers such as immunoassays, DNA sequencing, clinical chemistry, etc., and electrowetting-based digital microfludic biochips. The audience will next learn about design automation, design-for-testability, and reconfiguration aspects of digital microfluidic biochips. Synthesis tools will be described to map assay protocols from the lab bench to a droplet-based microfluidic platform and generate an optimized schedule of bioassay operations, the binding of assay operations to functional units, and the layout and droplet-flow paths for the biochip. The role of the digital microfluidic platform as a \\\"programmable and reconfigurable processor\\\" for biochemical applications will be highlighted. Finally, the speaker will demonstrate dynamic adaptation of bioassays through cyberphysical system integration and sensor-driven on-chip error recovery.\",\"PeriodicalId\":255133,\"journal\":{\"name\":\"Proceedings of the 25th edition on Great Lakes Symposium on VLSI\",\"volume\":\"15 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2015-05-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Proceedings of the 25th edition on Great Lakes Symposium on VLSI\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1145/2742060.2745701\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Proceedings of the 25th edition on Great Lakes Symposium on VLSI","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1145/2742060.2745701","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

基于微滴的“数字”微流体技术的进步导致了生物化学和分子生物学中用于自动化实验室程序的生物芯片设备的出现。这些装置能够精确控制生化样品和试剂的纳升体积液滴。因此,可以利用集成电路(IC)技术以微/纳米流体液滴的形式输送和输送“化学载荷”。因此,集成电路和系统的非传统生物医学应用和市场(例如,高通量DNA测序,便携式和护理点临床诊断,用于药物发现的蛋白质结晶)以及根本的新用途正在开放。然而,持续的增长取决于芯片集成和设计自动化工具的进步。设计自动化是必要的,以确保生物芯片与它们打算取代的宏观实验室一样通用,研究人员因此可以设想生物芯片的自动化设计流程,就像设计自动化在80年代和90年代彻底改变了IC设计一样。本讲座将首先概述市场驱动因素,如免疫分析、DNA测序、临床化学等,以及基于电润湿的数字微流控生物芯片。观众接下来将了解设计自动化,可测试性设计,以及数字微流控生物芯片的重新配置方面。将描述合成工具,将分析方案从实验室工作台映射到基于微流控平台,并生成生物分析操作的优化时间表,分析操作与功能单元的结合,以及生物芯片的布局和液滴流动路径。数字微流控平台作为生化应用的“可编程和可重构处理器”的作用将得到强调。最后,演讲者将通过网络物理系统集成和传感器驱动的片上错误恢复演示生物分析的动态适应。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Digital Microfluidic Biochips: Towards Functional Diversity, More than Moore, and Cyberphysical Integration
Advances in droplet-based "digital" microfluidics have led to the emergence of biochip devices for automating laboratory procedures in biochemistry and molecular biology. These devices enable the precise control of nanoliter-volume droplets of biochemical samples and reagents. Therefore, integrated circuit (IC) technology can be used to transport and transport "chemical payload" in the form of micro/nanofluidic droplets. As a result, non-traditional biomedical applications and markets (e.g., high-throughout DNA sequencing, portable and point-of-care clinical diagnostics, protein crystallization for drug discovery), and fundamentally new uses are opening up for ICs and systems. However, continued growth depends on advances in chip integration and design-automation tools. Design automation is needed to ensure that biochips are as versatile as the macro-labs that they are intended to replace, and researchers can thereby envision an automated design flow for biochips, in the same way as design automation revolutionized IC design in the 80s and 90s. This talk will first provide an overview of market drivers such as immunoassays, DNA sequencing, clinical chemistry, etc., and electrowetting-based digital microfludic biochips. The audience will next learn about design automation, design-for-testability, and reconfiguration aspects of digital microfluidic biochips. Synthesis tools will be described to map assay protocols from the lab bench to a droplet-based microfluidic platform and generate an optimized schedule of bioassay operations, the binding of assay operations to functional units, and the layout and droplet-flow paths for the biochip. The role of the digital microfluidic platform as a "programmable and reconfigurable processor" for biochemical applications will be highlighted. Finally, the speaker will demonstrate dynamic adaptation of bioassays through cyberphysical system integration and sensor-driven on-chip error recovery.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信